StockData
AEMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31

AETHLON MEDICAL INC

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.16+0.01 (+0.19%)

Close on Oct 19, 2026

Market cap
$1.99M
P/E (TTM)
–
Dividend yield
–

AETHLON MEDICAL INC revenue by segment

By business segment

RevenueQ1 23Q4 22Q3 22Q2 22Q1 22Q4 21Q3 21Q2 21Q1 21Q4 20Q3 20Q2 20% of revenueYoY
Aethlon [Member]$0$13.12K$17.12K$131.97K$131.97K$34.23K$624.87K$0$0$206.73K$413.46K$0–-100.0%
ESI [Member]$0$0$0$0$0$0$0$0$0$0$0$0––
Operating incomeQ1 23Q4 22Q3 22Q2 22Q1 22Q4 21Q3 21Q2 21Q1 21Q4 20Q3 20Q2 20YoY
ESI [Member]-$2.07K-$3.10K-$11.07K-$4.13K-$5.68K-$8.02K-$7.49K-$4.13K-$4.32K-$11.43K-$6.79K-$7.95K-63.6%
Aethlon [Member]-$2.90M-$3.78M-$2.52M-$2.00M-$2.09M-$2.26M-$2.44M-$1.77M-$1.41M-$1.77M-$869.62K-$1.69M+38.8%

By product or service

By region

From the segment and revenue-disaggregation notes of Aethlon Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.